![Prognosis of ovarian clear cell cancer compared with other epithelial cancer types: A population‑based analysis Prognosis of ovarian clear cell cancer compared with other epithelial cancer types: A population‑based analysis](https://www.spandidos-publications.com/article_images/ol/19/3/ol-19-03-1947-g02.jpg)
Prognosis of ovarian clear cell cancer compared with other epithelial cancer types: A population‑based analysis
![Analysis of the Overall survival for IQGAP3 in human cancers. (A) The... | Download Scientific Diagram Analysis of the Overall survival for IQGAP3 in human cancers. (A) The... | Download Scientific Diagram](https://www.researchgate.net/publication/358784090/figure/fig3/AS:1127758746927104@1645890046148/Analysis-of-the-Overall-survival-for-IQGAP3-in-human-cancers-A-The-overall-survival.png)
Analysis of the Overall survival for IQGAP3 in human cancers. (A) The... | Download Scientific Diagram
![Loss-of-function mutations in PPP2R1A Correlate with Exceptional Survival in Ovarian Clear Cell Carcinomas Treated with Immune Checkpoint Inhibitors (099) - ScienceDirect Loss-of-function mutations in PPP2R1A Correlate with Exceptional Survival in Ovarian Clear Cell Carcinomas Treated with Immune Checkpoint Inhibitors (099) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825822013257-fx1.jpg)
Loss-of-function mutations in PPP2R1A Correlate with Exceptional Survival in Ovarian Clear Cell Carcinomas Treated with Immune Checkpoint Inhibitors (099) - ScienceDirect
![A real-world 1:1 propensity-matched study revealed unmarried status was independently associated with worse survival for patients with renal clear cell carcinoma A real-world 1:1 propensity-matched study revealed unmarried status was independently associated with worse survival for patients with renal clear cell carcinoma](https://www.jcancer.org/v10/p3767/jcav10p3767g001.jpg)
A real-world 1:1 propensity-matched study revealed unmarried status was independently associated with worse survival for patients with renal clear cell carcinoma
![A Novel Nomogram Predicting the Overall Survival of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma: A Large Population-Based Investigation | SpringerLink A Novel Nomogram Predicting the Overall Survival of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma: A Large Population-Based Investigation | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1245%2Fs10434-023-13131-0/MediaObjects/10434_2023_13131_Fig1_HTML.png)
A Novel Nomogram Predicting the Overall Survival of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma: A Large Population-Based Investigation | SpringerLink
![A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance) - eBioMedicine A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance) - eBioMedicine](https://www.thelancet.com/cms/attachment/c292f39b-d5f7-46bc-afc1-b4a24c7d73da/gr1_lrg.jpg)
A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance) - eBioMedicine
![Stream Final Overall Survival Results of the CLEAR Study in Renal Cell Carcinoma With Thomas Hutson, MD by Oncology Data Advisor® | Listen online for free on SoundCloud Stream Final Overall Survival Results of the CLEAR Study in Renal Cell Carcinoma With Thomas Hutson, MD by Oncology Data Advisor® | Listen online for free on SoundCloud](https://i1.sndcdn.com/artworks-tR5yPysquDEpMb2V-E5ulsg-t500x500.jpg)
Stream Final Overall Survival Results of the CLEAR Study in Renal Cell Carcinoma With Thomas Hutson, MD by Oncology Data Advisor® | Listen online for free on SoundCloud
![ASCO 2023: Final Prespecified Overall Survival Analysis of CLEAR: 4-Year Follow-up of Lenvatinib + Pembrolizumab vs Sunitinib in Patients with Advanced RCC ASCO 2023: Final Prespecified Overall Survival Analysis of CLEAR: 4-Year Follow-up of Lenvatinib + Pembrolizumab vs Sunitinib in Patients with Advanced RCC](https://www.urotoday.com/images/com-doc-importer/124-asco-2023/asco-2023-final-prespecified-overall-survival-analysis-of-clear-4-year-follow-up-of-lenvatinib-pembrolizumab-vs-sunitinib-in-patients-with-advanced-rcc/image-0.jpg)
ASCO 2023: Final Prespecified Overall Survival Analysis of CLEAR: 4-Year Follow-up of Lenvatinib + Pembrolizumab vs Sunitinib in Patients with Advanced RCC
![Decreased expression of JMJD3 predicts poor prognosis of patients with clear cell renal cell carcinoma Decreased expression of JMJD3 predicts poor prognosis of patients with clear cell renal cell carcinoma](https://www.spandidos-publications.com/article_images/ol/14/2/ol-14-02-1550-g00.jpg)
Decreased expression of JMJD3 predicts poor prognosis of patients with clear cell renal cell carcinoma
Kaplan–Meier estimates the (A) cancer-specific and (B) overall survival... | Download Scientific Diagram
Artificial intelligence prediction model for overall survival of clear cell renal cell carcinoma based on a 21-gene molecular prognostic score system - Figure f1 | Aging
![Six RNA binding proteins (RBPs) related prognostic model predicts overall survival for clear cell renal cell carcinoma and is associated with immune infiltration | Biomolecules and Biomedicine Six RNA binding proteins (RBPs) related prognostic model predicts overall survival for clear cell renal cell carcinoma and is associated with immune infiltration | Biomolecules and Biomedicine](https://www.bjbms.org/ojs/public/journals/1/article_6097_cover_en_US.jpg)
Six RNA binding proteins (RBPs) related prognostic model predicts overall survival for clear cell renal cell carcinoma and is associated with immune infiltration | Biomolecules and Biomedicine
![IDH1 R132C mutation is detected in clear cell hepatocellular carcinoma by pyrosequencing | World Journal of Surgical Oncology | Full Text IDH1 R132C mutation is detected in clear cell hepatocellular carcinoma by pyrosequencing | World Journal of Surgical Oncology | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12957-017-1144-1/MediaObjects/12957_2017_1144_Fig4_HTML.gif)
IDH1 R132C mutation is detected in clear cell hepatocellular carcinoma by pyrosequencing | World Journal of Surgical Oncology | Full Text
![Progression-free survival and overall survival for patients with clear... | Download Scientific Diagram Progression-free survival and overall survival for patients with clear... | Download Scientific Diagram](https://www.researchgate.net/publication/363623109/figure/fig3/AS:11431281092635847@1666916384829/Progression-free-survival-and-overall-survival-for-patients-with-clear-cell-RCC-and.png)
Progression-free survival and overall survival for patients with clear... | Download Scientific Diagram
![Cancers | Free Full-Text | Evaluation of Survival, Recurrence Patterns and Adjuvant Therapy in Surgically Staged High-Grade Endometrial Cancer with Retroperitoneal Metastases Cancers | Free Full-Text | Evaluation of Survival, Recurrence Patterns and Adjuvant Therapy in Surgically Staged High-Grade Endometrial Cancer with Retroperitoneal Metastases](https://www.mdpi.com/cancers/cancers-13-02052/article_deploy/html/images/cancers-13-02052-g001.png)
Cancers | Free Full-Text | Evaluation of Survival, Recurrence Patterns and Adjuvant Therapy in Surgically Staged High-Grade Endometrial Cancer with Retroperitoneal Metastases
![ASCO 2022: Progression-Free Survival After Second Line of Therapy (PFS-2) for Metastatic Clear Cell RCC in Patients Treated With First-Line Immunotherapy Combinations ASCO 2022: Progression-Free Survival After Second Line of Therapy (PFS-2) for Metastatic Clear Cell RCC in Patients Treated With First-Line Immunotherapy Combinations](https://www.urotoday.com/images/com-doc-importer/70-asco-2022/asco-2022-progression-free-survival-after-second-line-of-therapy-pfs-2-for-metastatic-clear-cell-rcc-in-patients-treated-with-first-line-immunotherapy-combinations/image-2.jpg)
ASCO 2022: Progression-Free Survival After Second Line of Therapy (PFS-2) for Metastatic Clear Cell RCC in Patients Treated With First-Line Immunotherapy Combinations
![MP47-11 DIFFERENTIAL ASSOCIATION OF BODY MASS INDEX ON SURVIVAL OUTCOMES IN RENAL CELL CARCINOMA: IMPACT OF TUMOR HISTOLOGY | Journal of Urology MP47-11 DIFFERENTIAL ASSOCIATION OF BODY MASS INDEX ON SURVIVAL OUTCOMES IN RENAL CELL CARCINOMA: IMPACT OF TUMOR HISTOLOGY | Journal of Urology](https://www.auajournals.org/cms/asset/bf712121-cb77-4252-977c-4cf5504d1f13/ju.0000000000002618.11f1.gif)
MP47-11 DIFFERENTIAL ASSOCIATION OF BODY MASS INDEX ON SURVIVAL OUTCOMES IN RENAL CELL CARCINOMA: IMPACT OF TUMOR HISTOLOGY | Journal of Urology
![Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging | British Journal of Cancer Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6603116/MediaObjects/41416_2006_Article_BF6603116_Fig1_HTML.gif)
Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging | British Journal of Cancer
![Cancers | Free Full-Text | COL7A1 Expression Improves Prognosis Prediction for Patients with Clear Cell Renal Cell Carcinoma Atop of Stage Cancers | Free Full-Text | COL7A1 Expression Improves Prognosis Prediction for Patients with Clear Cell Renal Cell Carcinoma Atop of Stage](https://www.mdpi.com/cancers/cancers-15-02701/article_deploy/html/images/cancers-15-02701-g001-550.jpg)
Cancers | Free Full-Text | COL7A1 Expression Improves Prognosis Prediction for Patients with Clear Cell Renal Cell Carcinoma Atop of Stage
![Outcomes of Patients With Advanced Renal Cell Carcinoma With Non-Clear Cell Histology Treated With Systemic Therapy - Clinical Genitourinary Cancer Outcomes of Patients With Advanced Renal Cell Carcinoma With Non-Clear Cell Histology Treated With Systemic Therapy - Clinical Genitourinary Cancer](https://www.clinical-genitourinary-cancer.com/cms/asset/c192befa-de7d-4bc6-be23-fc5c1d94faa4/gr1.jpg)